Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
5.20
+2.19 (72.76%)
At close: Nov 7, 2025
RAJAF Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.25 | 1.25 | 0.88 | 0.05 | - | |
Revenue Growth | -0.65% | 42.03% | 1555.66% | -73.62% | - |
Cost of Revenue | 0.48 | 0.35 | 0.12 | 0.01 | - |
Gross Profit | 0.76 | 0.91 | 0.77 | 0.04 | - |
Selling, General & Admin | 0.9 | 1.09 | 0.54 | 0.34 | 0.09 |
Research & Development | - | - | - | 0.12 | 0.03 |
Operating Expenses | 0.9 | 1.09 | 0.54 | 0.45 | 0.12 |
Operating Income | -0.14 | -0.18 | 0.23 | -0.42 | -0.12 |
Interest Expense | -0.02 | -0.02 | -0.04 | - | - |
Interest & Investment Income | - | - | - | 0 | 0 |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0 | - | - |
EBT Excluding Unusual Items | -0.15 | -0.2 | 0.19 | -0.42 | -0.12 |
Gain (Loss) on Sale of Assets | - | 0 | - | - | - |
Pretax Income | -0.15 | -0.19 | 0.19 | -0.42 | -0.12 |
Income Tax Expense | - | 0.03 | 0.02 | - | - |
Earnings From Continuing Operations | -0.15 | -0.23 | 0.17 | -0.42 | -0.12 |
Earnings From Discontinued Operations | - | - | 0.58 | -0.3 | -0.37 |
Net Income | -0.15 | -0.23 | 0.75 | -0.72 | -0.49 |
Net Income to Common | -0.15 | -0.23 | 0.75 | -0.72 | -0.49 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 111 | 111 | 111 | 104 | 100 |
Shares Outstanding (Diluted) | 111 | 111 | 111 | 104 | 100 |
Shares Change | - | - | 6.42% | 4.42% | - |
EPS (Basic) | -0.00 | -0.00 | 0.01 | -0.01 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | 0.01 | -0.01 | -0.00 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -0.04 | -0.04 | 0.04 | -0.32 | -0.47 |
Free Cash Flow Per Share | - | - | - | -0.00 | -0.01 |
Gross Margin | 61.09% | 72.32% | 86.84% | 74.21% | - |
Operating Margin | -11.33% | -14.67% | 25.82% | -778.78% | - |
Profit Margin | -12.43% | -18.05% | 85.17% | -1350.92% | - |
Free Cash Flow Margin | -2.88% | -2.97% | 4.56% | -602.91% | - |
EBITDA | 0.07 | 0.24 | 0.28 | -0.39 | 0.03 |
EBITDA Margin | 5.47% | 19.16% | 32.25% | - | - |
D&A For EBITDA | 0.21 | 0.42 | 0.06 | 0.02 | 0.15 |
EBIT | -0.14 | -0.18 | 0.23 | -0.42 | -0.12 |
EBIT Margin | -11.33% | -14.67% | 25.82% | - | - |
Effective Tax Rate | - | - | 11.28% | - | - |
Revenue as Reported | 1.25 | 1.25 | 0.88 | 0.05 | - |